FHT-185

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameFHT-185
Drug Alias NameFHT-185
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProbable global transcription activator SNF2L2 inhibitorsSMARCA4 inhibitors
TargetsTranscription activator BRG1Probable global transcription activator SNF2L2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFoghorn Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesFoghorn Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A